Prostate Cancer Progression and the Epigenome

N Engl J Med. 2020 Dec 3;383(23):2287-2290. doi: 10.1056/NEJMcibr2030475.

Authors

Wadih Arap¹, Renata Pasqualini¹, Joseph F Costello¹

Affiliation

¹ From the Rutgers Cancer Institute of New Jersey (W.A., R.P.) and the Division of Hematology-Oncology, Department of Medicine (W.A.), and the Division of Cancer Biology, Department of Radiation Oncology (R.P.), Rutgers New Jersey Medical School, Newark; and the Department of Neurological Surgery, University of California, San Francisco, San Francisco (J.F.C.).

PMID: 33264551
DOI: 10.1056/NEJMcibr2030475

No abstract available

MeSH terms

Animals
Cell Line
Disease Progression*
Epigenome*
Gene Expression Regulation, Neoplastic
Heterografts
Humans
Male
Prostate / pathology
Prostatic Neoplasms / genetics*
Prostatic Neoplasms / pathology
Receptors, Androgen / genetics
Receptors, Androgen / metabolism
Regulatory Sequences, Nucleic Acid / genetics

Substances

Receptors, Androgen